Preclinical Imaging, Brain Health Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada.
Human Brain Laboratory, Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Psychopharmacology (Berl). 2020 Sep;237(9):2661-2671. doi: 10.1007/s00213-020-05562-4. Epub 2020 Jun 3.
The long-held speculation that the brain serotonin system mediates some behavioral effects of the psychostimulant cocaine is supported in part by the high affinity of cocaine for the serotonin transporter (SERT) and by reports that the serotonin transporter (SERT), estimated by SERT binding, is increased in brain of human chronic cocaine users. Excessive SERT activity and consequent synaptic serotonin deficiency might cause a behavioral (e.g., mood) abnormality in chronic users of the drug.
Previous studies focused on changes in SERT binding, which might not necessarily reflect changes in SERT protein. Therefore, we compared levels of SERT protein, using a quantitative Western blot procedure, in autopsied brain (striatum, cerebral cortices) of chronic human cocaine users (n = 9), who all tested positive for the drug/metabolite in brain, to those in control subjects (n = 15) and, as a separate drug of abuse group, in chronic heroin users (n = 11).
We found no significant difference in protein levels of SERT or the serotonin synthesizing enzyme tryptophan hydroxylase-2 among the control and drug abuse groups. In the cocaine users, no significant correlations were observed between SERT and brain levels of cocaine plus metabolites, or with levels of serotonin or its metabolite 5-hydroxyindoleacetic acid.
Our postmortem data suggest that a robust increase in striatal/cerebral cortical SERT protein is not a common characteristic of chronic, human cocaine users.
长期以来一直有推测认为,大脑中的血清素系统介导了精神兴奋剂可卡因的一些行为效应,这在一定程度上得到了可卡因对血清素转运蛋白(SERT)的高亲和力以及对人类慢性可卡因使用者大脑中 SERT 结合估计的 SERT 增加的报告的支持。SERT 活性过度和随之而来的突触血清素缺乏可能导致药物慢性使用者出现行为(例如情绪)异常。
以前的研究集中在 SERT 结合的变化上,而这不一定反映 SERT 蛋白的变化。因此,我们使用定量 Western blot 程序比较了 SERT 蛋白水平,该程序比较了慢性人类可卡因使用者(n = 9)尸检大脑(纹状体、大脑皮质)中的 SERT 蛋白水平,这些使用者的大脑中均检测到药物/代谢物呈阳性,与对照组(n = 15)和作为单独的滥用药物组的慢性海洛因使用者(n = 11)中的 SERT 蛋白水平。
我们在对照组和药物滥用组之间未发现 SERT 或色氨酸羟化酶-2 的蛋白水平有显著差异。在可卡因使用者中,SERT 与大脑中的可卡因加代谢物水平或与血清素或其代谢物 5-羟吲哚乙酸水平之间均无显著相关性。
我们的尸检数据表明,纹状体/大脑皮质 SERT 蛋白的显著增加并不是慢性人类可卡因使用者的常见特征。